期刊文献+

二氢青蒿素诱导乳腺癌细胞凋亡的分子机制初探 被引量:4

Effects of dihydroartemisinin on proliferation and apoptosis of breast carcinoma cell line T47D
原文传递
导出
摘要 目的:研究二氢青蒿素(DHA)对乳腺癌细胞系T47D的增殖、凋亡作用的影响,初步探讨其抗癌作用的分子机制。方法:以乳腺癌细胞T47D为研究对象,观测不同浓度和作用时间的DHA对T47D细胞的作用,MTT噻唑蓝比色法检测对细胞的增殖抑制作用,分别PI单染及Annexin-V双染法流式细胞术分析细胞周期分布和早期凋亡率的变化,RT-PCR和蛋白质印迹法检测细胞凋亡相关蛋白的表达。结果:DHA对T47D细胞有增殖抑制作用且呈剂量和时间依赖性,DHA作用24、48和72h的IC50值分别为60.03、33.86和17.18μmol/L;流式细胞仪检测细胞阻滞于G0/G1期,随药物剂量增大(20、40和60μmol/L),G0/G1期比例逐渐增高(42.76%、49.71%和63.01%),S期比例降低(48.45%、42.41%和30.98%);Annexin-V双染法示早期细胞凋亡率呈明显剂量依赖性升高〔(20.81±0.68)%、(30.90±0.73)%、(45.32±2.17)%(n=3)〕;RT-PCR检测显示,DHA作用后细胞凋亡诱导因子BimmR-NA的表达量升高;蛋白质印迹法检测DHA作用48h凋亡相关蛋白tbid和Caspase-8表达增强,且呈一定剂量依赖关系。结论:DHA能显著抑制人乳腺癌细胞T47D生长,影响细胞周期,诱导细胞凋亡,其分子机制可能与促使Bim、tbid和Caspase-8表达增强的内源性凋亡途径有关。 OBJECTIVE: To observe the effect of dihydroartemisinin (DHA) on the proliferation and apoptosis in human breast carcinoma cell line T47D in vitro and explore the mechanism. METHODS: The inhibition of proliferation of T47D ceils was determined by MTT assay. The distribution of cell cycle and apoptosis were analyzed by using flow cytometry through PI and AnnexinV/PI double-labeled staining. The expression of Bim mRNA was detected by RT-PCR, and the expression of cell apoptosis-associated gene proteins was detected with Western blot technique. RESULTS: Dihydroartemisinin could inhibit the proliferation of T47D cells and the inhibition was depended on the exposure dose and time. The ICs0 values after treatment by DHA for were 60.03, 33.86 and 17.18 μmol/L. After treated with Dihydroartemisinin for 24,48 and 72 h, the analysis of cell cycle indicated that Dihydroartemisinin blocked ceils at G0/G1 phases, showed an increase of G0/G1 phase (42.76 %, 49.71%, 63.01%) and a decrease of S phase (48.45%, 42.41%, 30.98%). When treated by 20,40,60 μmol/L of DHA for 48 h, the early apoptosis rates of breast cancer T47D cell were (20.81±0.68)%, (30.90±0.73)% , (45.32±2.17)% (n= 3), The higher the concentration, the higher the early apoptosis rates. The expression of Bim mRNA was up regulated, and tbid, caspase 8 expressions were up-regulated. CONCLUSIONS: DHA can inhibit the proliferation of the breast carcinoma cell line T47D by regulating the cell cycle through arresting cells at G0/G1 phase and inducing apoptosis. The anti-tumor effects may be related to the up-regulation of the expressions of gene Bim, tbid, and Caspase-8 proteins.
出处 《中华肿瘤防治杂志》 CAS 2009年第14期1051-1054,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 山东省自然科学基金(Y2002C45)
关键词 乳腺肿瘤 青蒿素 细胞凋亡 breast neoplasms artemisinin apoptosis
  • 相关文献

参考文献9

  • 1郭建红,丘明建.青蒿素类衍生物抗肿瘤研究进展[J].中国现代药物应用,2008,2(1):123-125. 被引量:5
  • 2Efferth T. Willmar Schwabe Award 2006:Antiplasmodial and antitumor activity of artemisinin from bench to bedside[J]. Planta Med, 2007,73(4) :299-309.
  • 3Nam W, Tak J, Ryu J K, et al Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells [J]. Head Neck,2007,29(4) :335-340.
  • 4Lai H, Singh N P. Oral artemisinin prevents and delays the development of 7,12 dimethylbenz[a] ant hracene (DMBA)-induced breast cancer in the rat[J]. Cancer Lett,2006,231(1):43-48.
  • 5Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells[J]. Current Drug Targets, 2006,7(11) :407-421.
  • 6Kuribara R, Honda H, Matsui H, et al. Roles of Bim in apoptosis of normal and Bcr-A bl expressing hematopoietic progenitors[J]. Mol Cell Bioi,2004,24 (14):6172-6183.
  • 7Bouillet P, Zhang L C, Huang D C, et al. Gene structure,alternative splicing,and chromosomal localization of proapoptotic Bel-2 relative[J]. Bim Mamm Genome,2001,12(2) : 163-168.
  • 8Yip K W,Li A,Li J H,et al. Potential utility of BimS as a novel apoptotic therapeutic molecule[J]. Mol Ther, 2004,10 (3) : 533- 544.
  • 9Shinoda S, Schindler C K, Quan Lan J, et al. Interaction of 14-3-3 with Bid during seizure-induced neuronal death[J]. J Neurochem, 2003,86(2) :460- 469.

二级参考文献16

  • 1赵莉霞,颜冰,黄培堂.转铁蛋白受体及其在药物运输中的作用[J].生命的化学,2004,24(6):468-469. 被引量:4
  • 2谢波,凌家俊.青蒿素及其衍生物抗肿瘤作用综述[J].广州中医药大学学报,2005,22(1):75-77. 被引量:11
  • 3[1]Wiesner,J,Ortmann,R,Jomaa,H,Schlitzer,M,2003.Newantimalarial drugs.Angew.Chem.Int.Ed.Engl.42,5274-5293.
  • 4[2]Meshnick,S.R,2002.Artemisinin:mechanisms of action,resistance and toxicity.Int.J.Parasitol.32,1655-1660.
  • 5[3]Dhingra,V,Vishweshwar Rao,K,Lakshmi Narasu,M,2000.Current status of artemisinin and its derivatives as antimalarial drugs.Life Sci.66,279-300.
  • 6[5]William J.The evolution of transferring.Trend Biochem.Sci,1982,7(11):394-397.
  • 7[8]Mamta Srivastava,Nils O,Petersen U.Diffusion of transferrin receptor clusters.Biophysical Chemistry,1998,75:201-211.
  • 8[9]Oxidative stress response of tumor cells:microarray-based comparison between artemisinins and anthracyclines.Biochem Pharmacol,2004,68(1):3-10.
  • 9[10]Moore,J.C,Lai,H,Li,J.R,Ren,R.L,McDougall,J.A,Singh,N.P,Chou,C.K,1995.Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.Cancer Lett,1998,83 -87.
  • 10[11]Lai,H,Singh,N.P,2006.Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a] ant-hracene (DMBA) -induced breast cancer in the rat.Cancer Lett.231,43-48.

共引文献4

同被引文献47

  • 1龚峻梅(综述),杜庆锋(审校),刘晓力(审校).青蒿素及其衍生物的抗肿瘤作用[J].国际肿瘤学杂志,2007,34(2):101-104. 被引量:4
  • 2李傲,周慧君.二氢青蒿素诱导HL-60细胞凋亡[J].中国药理学与毒理学杂志,2007,21(3):217-222. 被引量:7
  • 3Yang JIAO,Chun-min GE,Qing-hui MENG,Jian-ping CAO,Jian TONG,Sai-jun FAN.Dihydroartemisinin is an inhibitor of ovarian cancer cell growth[J].Acta Pharmacologica Sinica,2007,28(7):1045-1056. 被引量:41
  • 4Efferth T, Romero MR, Wolf DG, eta!. The antiviral activities of artemisinin and artesunate [J]. Clin Infect Dis, 2008, 47(6): 804-811.
  • 5Ohgami Y, Elstad CA, Chung E, et al. Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells [J]. Anticancer Res, 2010, 30(11): 4467- 4470.
  • 6Langroudi L, Hassan ZM, Ebtekar M, eta/. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model [J]. Int Immunopharmacol, 2010, 10(9): 1055-1061.
  • 7Chen H, Sun B, Pan S, eta!. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo [J]. Anticancer Drugs, 2009, 20(2): 131-140.
  • 8Lu JJ, Chen SM, Zhang XW, et ol. The anti-cancer activity of dihydroartemisinin is associated with induction ofiron-dependent e ndoplasmic reticulum stress in colorectal carcinoma HCT116 cells [J]. Invest New Drugs, 2011, 29(6): 1276-1283.
  • 9He Q, Shi J, Shen XL, et al. Dihydroartemisinin upregu- lates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells [J]. Cancer Biol Ther, 2010, 9(10): 819-824.
  • 10Gravett AM, Liu WM, Krishna S, et al. In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents [J]. Cancer Chemother Pharmacol, 2011, 67(3): 569-577.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部